MichaelHarryRosoveMD

PubMed

• Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia.
  Katie P. Truong, Jessica J. Zhang, Marwah Shahid, Aditya Goud, Michael H. Rosove, Jesse Currier, Kamran Shamsa, Rushi V. Parikh> ;JACC. Case Reports. 2021 Oct 20
• 2 citations
  “Spontaneous” Heparin-Induced Thrombocytopenia and Thrombosis After Total Knee Arthroplasty: A Report of 2 Cases
  Olga Olevsky, Michael H. Rosove> ;Arthroplasty Today. 2021 May 6
• 2 citations
  Hematologic Chaos in Lupus Flare: A Case of Fulminant and Simultaneous Antiphospholipid, Anti-ADAMTS13, and Red Blood Cell Autoantibodies.
  Jafar Al-Mondhiry, Caroline Y. Chen, Michael H. Rosove> ;Case Reports in Rheumatology. 2020 Nov 13
• 18 citations
  Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.
  John V. Hegde, Narek Shaverdian, Megan E. Daly, Carol Felix, Deborah L. Wong, Michael H. Rosove, Jordan H. Garst, Pin-Chieh Wang, Darlene Veruttipong, Shyam Rao, Ruben...> ;Cancer. 2018 Feb 1
• Prospective radiotherapy for patients with oropharyngeal carcinoma – Authors' reply
  Allen M. Chen, P.J. Beron, Deborah Wong, Michael H. Rosove, Shyam Rao, Michael L. Steinberg, Patrick A. Kupelian, Megan E. Daly> ;The Lancet. Oncology. 2017 Aug 1
• 226 citations
  Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
  Allen M. Chen, Carol Felix, Pin-Chieh Wang, R.N. Sophia Hsu, Vincent Basehart, Jordan H. Garst, P.J. Beron, Deborah Wong, Michael H. Rosove, Shyam Rao, Heather Melanso...> ;The Lancet. Oncology. 2017 Jun 1
• 1 citations
  Romiplostim mitigates dose-limiting thrombocytopenia of erucic acid for adrenomyeloneuropathy
  Daniel Sanghoon Shin, Susan Perlman, Michael H. Rosove> ;British Journal of Haematology. 2015 Apr 1
• 5 citations
  Thrombotic microangiopathies.
  Michael H Rosove> ;Seminars in Arthritis and Rheumatism. 2014 Jun 1
• 127 citations
  BRAF V600E inhibition in anaplastic thyroid cancer.
  Michael H Rosove, Parvin F. Peddi, John A. Glaspy> ;The New England Journal of Medicine. 2013 Feb 13
• Fulminant Wilson disease.
  Michael H. Rosove, Neeharika Srivastava> ;Blood. 2012 Oct 18
• 10 citations
  Triple-Drug Transcatheter Arterial Chemoembolization in Unresectable Hepatocellular Carcinoma: Assessment of Survival in 124 Consecutive Patients
  Antoinette S. Gomes, Michael H. Rosove, Peter Rosen, Rafael G. Amado, James Sayre, P. Monteleone, Ronald W. Busuttil> ;AJR. American Journal of Roentgenology. 2009 Dec 1
• 29 citations
  Should We Be Applying Warfarin Pharmacogenetics to Clinical Practice? No, Not Now
  Michael H. Rosove, Wayne W. Grody> ;Annals of Internal Medicine. 2009 Aug 18
• 19 citations
  Platelet glycoprotein IIb/IIIa inhibitors.
  Michael H. Rosove> ;Best Practice & Research. Clinical Haematology. 2004 Mar 1
• 6 citations
  Foundation and sites of action of antithrombotic agents.
  Victor J. Marder, Michael H. Rosove, Dena M Minning> ;Best Practice & Research. Clinical Haematology. 2004 Mar 1
• 75 citations
  Prevalence, causes and characterization of factor XI inhibitors in patients with inherited factor XI deficiency
  Ophira Salomon, Ariella Zivelin, Tami Livnat, Rima Dardik, Ron Loewenthal, Ophelia Avishai, David M. Steinberg, Michael H. Rosove, Niamh O'Connell, Christine A. Lee, U...> ;Blood. 2003 Jun 15
• 148 citations
  Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.
  Mitsugi Shimoda, Douglas G. Farmer, Steven D. Colquhoun, Michael H. Rosove, R. Mark Ghobrial, Pauline Chen, Ronald W. Busuttil, Hasan Yersiz> ;Liver Transplantation. 2001 Dec 1
• 70 citations
  Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia
  Honghao Yang, Michael H. Rosove, Robert A. Figlin> ;American Journal of Hematology. 1999 Dec 1
• 2 citations
  Continuous infusional 5-fluorouracil chemotherapy.
  Kimberly Olthoff, Michael H. Rosove, Christopher R. Shackleton, David K. Imagawa, Douglas G. Farmer, P Northcross, Anita Pakrasi, Paul L. Martin, Leonard I. Goldstein,...> ;Annals of Surgery. 1996 Nov 1
• 127 citations
  Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.
  Kim M. Olthoff, Michael H. Rosove, Christopher R. Shackleton, David K. Imagawa, Douglas G. Farmer, Petronella Northcross, Anita Pakrasi, Paul Martin, Leonard I. Goldst...> ;Annals of Surgery. 1995 Jun 1
• 25 citations
  Fatal Sepsis Due to a β-Lactamase-Producing Strain of Fusobacterium nucleatum subspecies polymorphum
  Ellie J. C. Goldstein, Paula H. Summanen, Diane M. Citron, Michael H. Rosove, Sydney M. Finegold> ;Clinical Infectious Diseases. 1995 Apr 1
• 218 citations
  Current treatment modalities for hepatocellular carcinoma
  Douglas G. Farmer, Michael H. Rosove, Abraham Shaked, Ronald W. Busuttil> ;Annals of Surgery. 1994 Mar 1
• 10 citations
  Perioperative coagulopathy in patients undergoing primary cytoreduction
  John V. Brown, Beth Y. Karlan, Jeffrey S. Greenspoon, Michael H. Rosove, Leo D. Lagasse> ;Cancer. 1993 Apr 15
• 13 citations
  Reversal of neutropenia with granulocyte colony-stimulating factor without precipitating liver allograft rejection.
  Steven D. Colquhoun, Abraham Shaked, O. Jurim, John O. Colonna, Michael H. Rosove, Ronald W. Busuttil> ;Transplantation. 1993 Jan 1
• 506 citations
  Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients
  Michael H. Rosove, Petronella M. C. Brewer> ;Annals of Internal Medicine. 1992 Aug 15
• 25 citations
  Cyanotic congenital heart disease: hematologic management.
  Mary C. Territo, Michael H. Rosove> ;Journal of the American College of Cardiology. 1991 Aug 1
• Join now to see all